0 XP   0   0   0

Bayer CropScience Limited
Buy, Hold or Sell?

Should you buy, hold or sell Bayer CropScience Limited?

I guess you are interested in Bayer CropScience Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Bayer CropScience Limited

Let's start. I'm going to help you getting a better view of Bayer CropScience Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Bayer CropScience Limited even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Bayer CropScience Limited is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Bayer CropScience Limited. The closing price on 2023-01-27 was INR4,497 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Bayer CropScience Limited Daily Candlestick Chart
Bayer CropScience Limited Daily Candlestick Chart
Summary









1. Valuation of Bayer CropScience Limited




Current price per share

INR4,496.70

2. Growth of Bayer CropScience Limited




Is Bayer CropScience Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$310.4m$313.6m-$3.1m-1.0%

How much money is Bayer CropScience Limited making?

Current yearPrevious yearGrowGrow %
Making money$79.3m$60.6m$18.7m23.6%
Net Profit Margin13.6%11.6%--

How much money comes from the company's main activities?

3. Financial Health of Bayer CropScience Limited




Comparing to competitors in the Chemicals industry




  Industry Rankings (Chemicals)  


Richest
#24 / 75

Most Revenue
#17 / 75

Most Profit
#16 / 75


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Bayer CropScience Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bayer CropScience Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Bayer CropScience Limited to the Chemicals industry mean.
  • A Net Profit Margin of 13.6% means that ₹0.14 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bayer CropScience Limited:

  • The MRQ is 13.6%. The company is making a huge profit. +2
  • The TTM is 13.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ13.6%TTM13.6%0.0%
TTM13.6%YOY11.6%+2.1%
TTM13.6%5Y12.0%+1.6%
5Y12.0%10Y11.5%+0.5%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ13.6%9.3%+4.3%
TTM13.6%8.9%+4.7%
YOY11.6%9.8%+1.8%
5Y12.0%8.7%+3.3%
10Y11.5%8.7%+2.8%
1.1.2. Return on Assets

Shows how efficient Bayer CropScience Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bayer CropScience Limited to the Chemicals industry mean.
  • 14.8% Return on Assets means that Bayer CropScience Limited generated ₹0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bayer CropScience Limited:

  • The MRQ is 14.8%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 14.8%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ14.8%TTM14.8%0.0%
TTM14.8%YOY11.6%+3.2%
TTM14.8%5Y12.0%+2.8%
5Y12.0%10Y11.9%+0.1%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ14.8%2.0%+12.8%
TTM14.8%2.0%+12.8%
YOY11.6%1.9%+9.7%
5Y12.0%2.0%+10.0%
10Y11.9%2.0%+9.9%
1.1.3. Return on Equity

Shows how efficient Bayer CropScience Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bayer CropScience Limited to the Chemicals industry mean.
  • 25.6% Return on Equity means Bayer CropScience Limited generated ₹0.26 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bayer CropScience Limited:

  • The MRQ is 25.6%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 25.6%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ25.6%TTM25.6%0.0%
TTM25.6%YOY19.3%+6.2%
TTM25.6%5Y19.1%+6.5%
5Y19.1%10Y18.1%+1.0%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ25.6%3.1%+22.5%
TTM25.6%3.9%+21.7%
YOY19.3%3.7%+15.6%
5Y19.1%3.4%+15.7%
10Y18.1%3.1%+15.0%

1.2. Operating Efficiency of Bayer CropScience Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bayer CropScience Limited is operating .

  • Measures how much profit Bayer CropScience Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bayer CropScience Limited to the Chemicals industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bayer CropScience Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y9.5%-9.5%
5Y9.5%10Y9.1%+0.4%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.9%-9.9%
TTM-6.7%-6.7%
YOY-9.6%-9.6%
5Y9.5%8.2%+1.3%
10Y9.1%8.8%+0.3%
1.2.2. Operating Ratio

Measures how efficient Bayer CropScience Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Chemicals industry mean).
  • An Operation Ratio of 1.38 means that the operating costs are ₹1.38 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Bayer CropScience Limited:

  • The MRQ is 1.376. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.376. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.376TTM1.3760.000
TTM1.376YOY1.408-0.032
TTM1.3765Y1.368+0.008
5Y1.36810Y1.265+0.103
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3761.436-0.060
TTM1.3761.415-0.039
YOY1.4081.385+0.023
5Y1.3681.390-0.022
10Y1.2651.356-0.091

1.3. Liquidity of Bayer CropScience Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bayer CropScience Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Chemicals industry mean).
  • A Current Ratio of 2.15 means the company has ₹2.15 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Bayer CropScience Limited:

  • The MRQ is 2.155. The company is able to pay all its short-term debts. +1
  • The TTM is 2.155. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.155TTM2.1550.000
TTM2.155YOY2.256-0.102
TTM2.1555Y2.507-0.352
5Y2.50710Y2.840-0.333
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1551.952+0.203
TTM2.1551.843+0.312
YOY2.2562.044+0.212
5Y2.5071.892+0.615
10Y2.8401.799+1.041
1.3.2. Quick Ratio

Measures if Bayer CropScience Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bayer CropScience Limited to the Chemicals industry mean.
  • A Quick Ratio of 1.24 means the company can pay off ₹1.24 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bayer CropScience Limited:

  • The MRQ is 1.237. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.237. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.237TTM1.2370.000
TTM1.237YOY1.524-0.287
TTM1.2375Y1.557-0.320
5Y1.55710Y1.754-0.197
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2371.084+0.153
TTM1.2371.153+0.084
YOY1.5241.296+0.228
5Y1.5571.062+0.495
10Y1.7541.040+0.714

1.4. Solvency of Bayer CropScience Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bayer CropScience Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bayer CropScience Limited to Chemicals industry mean.
  • A Debt to Asset Ratio of 0.42 means that Bayer CropScience Limited assets are financed with 42.0% credit (debt) and the remaining percentage (100% - 42.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bayer CropScience Limited:

  • The MRQ is 0.420. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.420. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.420TTM0.4200.000
TTM0.420YOY0.398+0.022
TTM0.4205Y0.363+0.057
5Y0.36310Y0.333+0.030
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4200.419+0.001
TTM0.4200.411+0.009
YOY0.3980.411-0.013
5Y0.3630.424-0.061
10Y0.3330.428-0.095
1.4.2. Debt to Equity Ratio

Measures if Bayer CropScience Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bayer CropScience Limited to the Chemicals industry mean.
  • A Debt to Equity ratio of 72.4% means that company has ₹0.72 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bayer CropScience Limited:

  • The MRQ is 0.724. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.724. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.724TTM0.7240.000
TTM0.724YOY0.662+0.062
TTM0.7245Y0.578+0.147
5Y0.57810Y0.512+0.065
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7240.724+0.000
TTM0.7240.711+0.013
YOY0.6620.736-0.074
5Y0.5780.807-0.229
10Y0.5120.790-0.278

2. Market Valuation of Bayer CropScience Limited

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Bayer CropScience Limited generates.

  • Above 15 is considered overpriced but always compare Bayer CropScience Limited to the Chemicals industry mean.
  • A PE ratio of 34.36 means the investor is paying ₹34.36 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bayer CropScience Limited:

  • The EOD is 31.317. Good. +1
  • The MRQ is 34.363. Good. +1
  • The TTM is 34.363. Good. +1
Trends
Current periodCompared to+/- 
EOD31.317MRQ34.363-3.045
MRQ34.363TTM34.3630.000
TTM34.363YOY49.526-15.163
TTM34.3635Y42.314-7.952
5Y42.31410Y37.533+4.781
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD31.31741.239-9.922
MRQ34.36343.506-9.143
TTM34.36344.322-9.959
YOY49.52660.045-10.519
5Y42.31461.018-18.704
10Y37.53358.271-20.738
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Bayer CropScience Limited.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Bayer CropScience Limited:

  • The MRQ is 26.258. Seems overpriced? -1
  • The TTM is 26.258. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ26.258TTM26.2580.000
TTM26.258YOY47.658-21.400
TTM26.2585Y38.310-12.052
5Y38.31010Y38.3100.000
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ26.2580.105+26.153
TTM26.2580.095+26.163
YOY47.6580.109+47.549
5Y38.3100.115+38.195
10Y38.3100.116+38.194

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bayer CropScience Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Chemicals industry mean).
  • A PB ratio of 8.78 means the investor is paying ₹8.78 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Bayer CropScience Limited:

  • The EOD is 8.006. Seems overpriced? -1
  • The MRQ is 8.784. Seems overpriced? -1
  • The TTM is 8.784. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD8.006MRQ8.784-0.778
MRQ8.784TTM8.7840.000
TTM8.784YOY9.576-0.792
TTM8.7845Y7.931+0.853
5Y7.93110Y6.699+1.232
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD8.0061.704+6.302
MRQ8.7841.911+6.873
TTM8.7842.026+6.758
YOY9.5761.803+7.773
5Y7.9311.686+6.245
10Y6.6991.437+5.262
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Bayer CropScience Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---5.785-5.7850%-4.940-15%-4.013-31%93.613-106%
Book Value Growth--0.9900.9900%0.9910%1.051-6%1.062-7%
Book Value Per Share--561.678561.6780%567.464-1%574.348-2%493.355+14%
Book Value Per Share Growth--0.9900.9900%0.9910%1.002-1%1.002-1%
Current Ratio--2.1552.1550%2.256-5%2.507-14%2.840-24%
Debt To Asset Ratio--0.4200.4200%0.398+5%0.363+16%0.333+26%
Debt To Equity Ratio--0.7240.7240%0.662+9%0.578+25%0.512+41%
Dividend Per Share--149.704149.7040%114.814+30%68.255+119%59.703+151%
Dividend Per Share Growth--1.3041.3040%5.084-74%2.027-36%2.027-36%
Eps--143.585143.5850%109.719+31%108.895+32%89.541+60%
Eps Growth--1.3091.3090%1.039+26%1.122+17%1.122+17%
Free Cash Flow Per Share--35.62435.6240%143.451-75%88.945-60%78.938-55%
Free Cash Flow Per Share Growth--0.2480.2480%1.032-76%1.599-84%1.599-84%
Free Cash Flow To Equity Per Share---120.867-120.8670%19.781-711%-16.759-86%-12.603-90%
Free Cash Flow To Equity Per Share Growth---6.110-6.1100%0.187-3374%-3.927-36%-3.927-36%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--353.045--------
Intrinsic Value_10Y_min--302.724--------
Intrinsic Value_1Y_max--35.651--------
Intrinsic Value_1Y_min--34.642--------
Intrinsic Value_3Y_max--106.908--------
Intrinsic Value_3Y_min--100.971--------
Intrinsic Value_5Y_max--177.915--------
Intrinsic Value_5Y_min--163.379--------
Net Profit Margin--0.1360.1360%0.116+18%0.120+14%0.115+18%
Operating Margin----0%-0%0.095-100%0.091-100%
Operating Ratio--1.3761.3760%1.408-2%1.368+1%1.265+9%
Pb Ratio8.006-10%8.7848.7840%9.576-8%7.931+11%6.699+31%
Pe Ratio31.317-10%34.36334.3630%49.526-31%42.314-19%37.533-8%
Peg Ratio--26.25826.2580%47.658-45%38.310-31%38.310-31%
Price Per Share4496.700-10%4933.9504933.9500%5433.950-9%4520.870+9%4325.343+14%
Price To Total Gains Ratio31.245-10%34.28334.2830%49.456-31%-9.994+129%-7.156+121%
Profit Growth--1.3091.3090%1.039+26%1.182+11%1.139+15%
Quick Ratio--1.2371.2370%1.524-19%1.557-21%1.754-29%
Return On Assets--0.1480.1480%0.116+27%0.120+23%0.119+24%
Return On Equity--0.2560.2560%0.193+32%0.191+34%0.181+41%
Revenue Growth--1.1111.1110%1.181-6%1.103+1%1.089+2%
Total Gains Per Share--143.919143.9190%109.875+31%64.242+124%153.316-6%
Total Gains Per Share Growth--1.3101.3100%3.919-67%2.101-38%2.101-38%
Usd Book Value--310488900.000310488900.0000%313686900.000-1%286954080.000+8%273427242.857+14%
Usd Book Value Change Per Share---0.071-0.0710%-0.061-15%-0.049-31%1.151-106%
Usd Book Value Per Share--6.9096.9090%6.980-1%7.064-2%6.068+14%
Usd Dividend Per Share--1.8411.8410%1.412+30%0.840+119%0.734+151%
Usd Eps--1.7661.7660%1.350+31%1.339+32%1.101+60%
Usd Free Cash Flow--19692300.00019692300.0000%79298100.000-75%45861780.000-57%32758414.286-40%
Usd Free Cash Flow Per Share--0.4380.4380%1.764-75%1.094-60%0.971-55%
Usd Free Cash Flow To Equity Per Share---1.487-1.4870%0.243-711%-0.206-86%-0.155-90%
Usd Price Per Share55.309-10%60.68860.6880%66.838-9%55.607+9%53.202+14%
Usd Profit--79371900.00079371900.0000%60651300.000+31%55352460.000+43%50187514.286+58%
Usd Revenue--582331200.000582331200.0000%524139900.000+11%455626440.000+28%428025942.857+36%
Usd Total Gains Per Share--1.7701.7700%1.351+31%0.790+124%1.886-6%
 EOD+3 -2MRQTTM+0 -0YOY+18 -235Y+19 -2310Y+19 -23

3.2. Fundamental Score

Let's check the fundamental score of Bayer CropScience Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1531.317
Price to Book Ratio (EOD)Between0-18.006
Net Profit Margin (MRQ)Greater than00.136
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.237
Current Ratio (MRQ)Greater than12.155
Debt to Asset Ratio (MRQ)Less than10.420
Debt to Equity Ratio (MRQ)Less than10.724
Return on Equity (MRQ)Greater than0.150.256
Return on Assets (MRQ)Greater than0.050.148
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Bayer CropScience Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose4,469.950
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets43,529,000
Total Liabilities18,286,000
Total Stockholder Equity25,243,000
 As reported
Total Liabilities 18,286,000
Total Stockholder Equity+ 25,243,000
Total Assets = 43,529,000

Assets

Total Assets43,529,000
Total Current Assets35,755,000
Long-term Assets35,755,000
Total Current Assets
Cash And Cash Equivalents 535,000
Short-term Investments 2,284,000
Net Receivables 10,047,000
Inventory 15,469,000
Other Current Assets 683,000
Total Current Assets  (as reported)35,755,000
Total Current Assets  (calculated)29,018,000
+/- 6,737,000
Long-term Assets
Property Plant Equipment 4,504,000
Intangible Assets 893,000
Other Assets 2,018,000
Long-term Assets  (as reported)7,774,000
Long-term Assets  (calculated)7,415,000
+/- 359,000

Liabilities & Shareholders' Equity

Total Current Liabilities16,593,000
Long-term Liabilities1,693,000
Total Stockholder Equity25,243,000
Total Current Liabilities
Accounts payable 8,198,000
Other Current Liabilities 1,171,000
Total Current Liabilities  (as reported)16,593,000
Total Current Liabilities  (calculated)9,369,000
+/- 7,224,000
Long-term Liabilities
Long term Debt Total 518,000
Capital Lease Obligations Min Short Term Debt864,000
Long-term Liabilities  (as reported)1,693,000
Long-term Liabilities  (calculated)1,382,000
+/- 311,000
Total Stockholder Equity
Common Stock449,000
Retained Earnings 23,400,000
Capital Surplus 1,394,000
Total Stockholder Equity (as reported)25,243,000
Total Stockholder Equity (calculated)25,243,000
+/-0
Other
Capital Stock449,000
Cash And Equivalents5,375,000
Cash and Short Term Investments 8,194,000
Common Stock Shares Outstanding 44,942
Liabilities and Stockholders Equity 43,529,000
Net Invested Capital 25,243,000
Net Working Capital 19,162,000



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
24,368,000
28,254,000
25,348,000
35,492,000
38,357,000
42,393,000
43,529,000
43,529,00042,393,00038,357,00035,492,00025,348,00028,254,00024,368,000
   > Total Current Assets 
20,219,000
23,742,000
20,761,000
27,798,000
30,144,000
35,439,000
35,755,000
35,755,00035,439,00030,144,00027,798,00020,761,00023,742,00020,219,000
       Cash And Cash Equivalents 
7,335,000
5,975,000
110,000
2,579,000
7,593,000
348,000
535,000
535,000348,0007,593,0002,579,000110,0005,975,0007,335,000
       Short-term Investments 
0
497,000
3,112,000
2,554,000
408,000
3,815,000
2,284,000
2,284,0003,815,000408,0002,554,0003,112,000497,0000
       Net Receivables 
4,050,000
5,565,000
6,588,000
6,986,000
7,180,000
7,549,000
10,047,000
10,047,0007,549,0007,180,0006,986,0006,588,0005,565,0004,050,000
       Inventory 
6,682,000
7,749,000
7,514,000
11,799,000
9,872,000
13,565,000
15,469,000
15,469,00013,565,0009,872,00011,799,0007,514,0007,749,0006,682,000
       Other Current Assets 
592,000
507,000
1,943,000
545,000
508,000
266,000
683,000
683,000266,000508,000545,0001,943,000507,000592,000
   > Long-term Assets 
0
4,512,000
4,587,000
8,107,000
8,213,000
6,954,000
7,774,000
7,774,0006,954,0008,213,0008,107,0004,587,0004,512,0000
       Property Plant Equipment 
2,945,000
3,062,000
3,012,000
4,139,000
4,399,000
4,008,000
4,504,000
4,504,0004,008,0004,399,0004,139,0003,012,0003,062,0002,945,000
       Intangible Assets 
127,000
292,000
391,000
426,000
540,000
702,000
893,000
893,000702,000540,000426,000391,000292,000127,000
       Long-term Assets Other 
0
0
0
0
0
255,000
259,000
259,000255,00000000
> Total Liabilities 
5,974,000
7,687,000
7,565,000
13,098,000
12,632,000
16,890,000
18,286,000
18,286,00016,890,00012,632,00013,098,0007,565,0007,687,0005,974,000
   > Total Current Liabilities 
5,224,000
6,831,000
6,619,000
11,879,000
11,394,000
15,706,000
16,593,000
16,593,00015,706,00011,394,00011,879,0006,619,0006,831,0005,224,000
       Short-term Debt 
0
0
0
0
15,000
0
0
0015,0000000
       Short Long Term Debt 
0
0
0
0
15,000
0
0
0015,0000000
       Accounts payable 
0
2,874,000
2,838,000
4,990,000
4,749,000
8,303,000
8,198,000
8,198,0008,303,0004,749,0004,990,0002,838,0002,874,0000
       Other Current Liabilities 
0
37,000
37,000
857,000
946,000
5,494,000
1,171,000
1,171,0005,494,000946,000857,00037,00037,0000
   > Long-term Liabilities 
0
856,000
946,000
1,137,000
1,238,000
1,184,000
1,693,000
1,693,0001,184,0001,238,0001,137,000946,000856,0000
       Long term Debt Total 
0
0
0
0
138,000
141,000
518,000
518,000141,000138,0000000
> Total Stockholder Equity
18,394,000
20,567,000
17,783,000
22,394,000
25,725,000
25,503,000
25,243,000
25,243,00025,503,00025,725,00022,394,00017,783,00020,567,00018,394,000
   Common Stock
354,000
354,000
343,000
449,000
449,000
449,000
449,000
449,000449,000449,000449,000343,000354,000354,000
   Retained Earnings 
18,040,000
20,213,000
17,440,000
20,551,000
23,882,000
23,660,000
23,400,000
23,400,00023,660,00023,882,00020,551,00017,440,00020,213,00018,040,000
   Capital Surplus 
0
0
0
1,394,000
1,394,000
1,394,000
1,394,000
1,394,0001,394,0001,394,0001,394,000000
   Treasury Stock0000000
   Other Stockholders Equity 0000000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue47,344,000
Cost of Revenue-26,988,000
Gross Profit20,356,00020,356,000
 
Operating Income (+$)
Gross Profit20,356,000
Operating Expense-38,164,000
Operating Income8,169,000-17,808,000
 
Operating Expense (+$)
Research Development-
Selling General Administrative11,871,000
Selling And Marketing Expenses-
Operating Expense38,164,00011,871,000
 
Net Interest Income (+$)
Interest Income313,000
Interest Expense-5,000
Net Interest Income116,000308,000
 
Pretax Income (+$)
Operating Income8,169,000
Net Interest Income116,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)8,468,0008,169,000
EBIT - interestExpense = -5,000
6,453,000
6,458,000
Interest Expense5,000
Earnings Before Interest and Taxes (ebit)-8,473,000
Earnings Before Interest and Taxes (ebitda)9,242,000
 
After tax Income (+$)
Income Before Tax8,468,000
Tax Provision-2,015,000
Net Income From Continuing Ops6,453,0006,453,000
Net Income6,453,000
Net Income Applicable To Common Shares6,453,000
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--116,000
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
NGU24-NYM.COMM
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGU24-NYM.COMM.

NGU24-NYM.COMM Daily Candlestick Chart
NGM24-NYM.COMM
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGM24-NYM.COMM.

NGM24-NYM.COMM Daily Candlestick Chart
NGQ24-NYM.COMM
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGQ24-NYM.COMM.

NGQ24-NYM.COMM Daily Candlestick Chart
ISKJ.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ISKJ.MCX.

ISKJ.MCX Daily Candlestick Chart
CHKZ.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHKZ.MCX.

CHKZ.MCX Daily Candlestick Chart
VSYD.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VSYD.MCX.

VSYD.MCX Daily Candlestick Chart
VRSB.MCX
2 hours ago

I found you a Golden Cross on the daily chart of VRSB.MCX.

VRSB.MCX Daily Candlestick Chart
TBRU.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBRU.MCX.

TBRU.MCX Daily Candlestick Chart
SNGSP.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SNGSP.MCX.

SNGSP.MCX Daily Candlestick Chart
RBCM.MCX
2 hours ago

I found you a Golden Cross on the daily chart of RBCM.MCX.

RBCM.MCX Daily Candlestick Chart
OKEY.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OKEY.MCX.

OKEY.MCX Daily Candlestick Chart
MTLR.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MTLR.MCX.

MTLR.MCX Daily Candlestick Chart
MRKZ.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MRKZ.MCX.

MRKZ.MCX Daily Candlestick Chart
KRKN.MCX
2 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of KRKN.MCX.

KRKN.MCX Daily Candlestick Chart
JNOS.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JNOS.MCX.

JNOS.MCX Daily Candlestick Chart
BLNG.MCX
2 hours ago

I found you a Golden Cross on the daily chart of BLNG.MCX.

BLNG.MCX Daily Candlestick Chart
ASSB.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ASSB.MCX.

ASSB.MCX Daily Candlestick Chart
CSYZ.MU
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CSYZ.MU.

CSYZ.MU Daily Candlestick Chart
MOH.MU
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MOH.MU.

MOH.MU Daily Candlestick Chart
TBK.V
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBK.V.

TBK.V Daily Candlestick Chart
UMDK.F
2 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of UMDK.F.

UMDK.F Daily Candlestick Chart
RY4C.BE
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RY4C.BE.

RY4C.BE Daily Candlestick Chart
PLY.BE
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PLY.BE.

PLY.BE Daily Candlestick Chart
PDL.LSE
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PDL.LSE.

PDL.LSE Daily Candlestick Chart
27F0.MU
2 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of 27F0.MU.

27F0.MU Daily Candlestick Chart